Filter
4581
Filtered Results: 4581
Text search:
efficacy
Featured
Recommendations
458
New Publications
998
Language
Document type
No document type
2273
Guidelines
853
Studies & Reports
709
Manuals
235
Strategic & Response Plan
192
Fact sheets
130
Training Material
103
Situation Updates
26
Infographics
18
Resource Platforms
17
Brochures
13
Online Courses
6
Videos
6
Countries / Regions
Global
191
India
148
Congo, Democratic Republic of
135
Senegal
120
South Africa
89
Kenya
83
Burkina Faso
77
Africa
68
Ethiopia
65
Uganda
64
Western and Central Europe
58
Nigeria
56
Benin
55
Latin America and the Carribbean
55
Tanzania
55
Sierra Leone
51
Haiti
51
Rwanda
47
Liberia
46
West and Central Africa
44
Zambia
44
Nepal
42
Cameroon
42
Malawi
41
Guinea
41
Ghana
38
Russia
34
Bangladesh
32
Mali
32
East and Southern Africa
30
Eastern Europe
27
Zimbabwe
25
Philippines
25
Brazil
25
South–East Asia Region
24
Côte d’Ivoire / Ivory Coast
24
Indonesia
24
Ukraine
23
Myanmar / Burma
23
Namibia
22
Central African Republic
22
Madagascar
22
Mozambique
21
Middle East and North Africa
20
Germany
18
Syria
17
Cambodia
17
Niger
16
Lesotho
15
Chad
14
Botswana
14
Pakistan
13
Togo
11
Asia
11
South Sudan
11
Eswatini/ Swaziland
11
Argentina
10
Eastern Europe and Central Asia
9
Sri Lanka
9
Chile
8
Laos
8
Vietnam
8
Sudan
8
Angola
8
Thailand
7
Peru
7
USA
7
North America
7
Somalia
7
Afghanistan
6
Jordan
6
Western Pacific Region
6
Paraguay
6
Yemen
6
Tajikistan
5
Colombia
5
China
5
Burundi
5
Italy
5
Guinea-Bissau
5
France
5
United Kingdom
5
Georgia
5
Iraq
5
Iran
4
Venezuela
4
Lebanon
4
Ecuador
4
North Macedonia
3
Morocco
3
Armenia
3
Tunisia
3
Bhutan
3
Switzerland
2
Mexico
2
Turkey
2
Albania
2
Canada
2
Congo-Brazzaville
2
Mauritania
2
Gabon
2
Portugal
2
Spain
2
Papua New Guinea
2
Honduras
2
Libya
2
Timor Leste/ East Timor
1
El Salvador
1
Serbia
1
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Uzbekistan
1
Qatar
1
Dominican Republic
1
Ireland
1
Saudi Arabia
1
Denmark
1
Belgium
1
Mauritius
1
Algeria
1
Belarus
1
Bolivia
1
Belize
1
Costa Rica
1
Guyana
1
Panama
1
Nicaragua
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1555
Clinical Guidelines
450
Public Health
261
Women & Child Health
235
Key Resources
187
Capacity Building
73
Pharmacy & Technologies
54
Toolboxes
COVID-19
514
Mental Health
408
HIV
316
TB
242
NTDs
200
AMR
185
Ebola & Marburg
160
Malaria
158
Rapid Response
151
Pharmacy
138
Caregiver
123
Disability
103
Planetary Health
90
NCDs
83
Refugee
53
Cholera
35
Conflict
31
Global Health Education
30
Polio
24
Health Financing Toolbox
23
Zika
22
Natural Hazards
20
Social Ethics
15
Specific Hazards
12
14.04.2016
Pharm -Ed
--
The alcohol-based solution for hand hygiene is now part of the WHO essential medicines list .Local production of the alcohol-based handrub is an alternative to commercial products. Although adapted to contexts with limited resources, it is essential to respect the Good Man...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
Recent systematic reviews and meta-analysis of the impact of chemical-based mollusciciding (King et al., 2015, Sokolow et al., 2016) have concluded that regular mollusciciding is likely to contribute significantly towards elimination of schistosomiasis in high-risk areas. The WHO roadmap’s new foc...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
Glob Ment Health (Camb). 2015; 2: e12. Published online 2015 Jul 14. doi: 10.1017/gmh.2015.10
Low and middle income countries (LMICs) are facing an increase of the impact of mental health problems while confronted with limited resources and limited access to mental health care, known as the ‘me...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
West Africa is experiencing the largest, most severe, most complex outbreak of Ebola virus disease in history. On 11 August 2014, WHO convened a consultation where the participants concluded that in the particular context of the current Ebola outbreak in West Africa, it is ethically acceptable to of...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
BMJ Global Health, Vol. 4 (2019) no.2
Antibiotic resistance is threatening global health, development and food security; however, measures for assessing and communicating the threat of resistance are lacking. The Drug Resistance Index (DRI) allows for global assessment of the relative efficacy of ...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Similar to other parts of the world, the prevalence of type 2 diabetes mellitus (T2DM) in the Asia-Pacific Region has rapidly increased during the last few decades. The purposes of this pilot study were to determine the feasibility and the effects of a capacity building program for Village Health Vo...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
